Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:746-752

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Song, L.
Right arrow Articles by Healy, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Song, L.
Right arrow Articles by Healy, D. P.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Hypertension - basic studies
Right arrow Receptor pharmacology

(Hypertension. 1999;33:746-752.)
© 1999 American Heart Association, Inc.


Scientific Contribution

Kidney Aminopeptidase A and Hypertension, Part II

Effects of Angiotensin II

Lijun Song; Dennis P. Healy

From the Department of Pharmacology, Mount Sinai School of Medicine of the City University of New York, New York, NY.

Correspondence to Dr Dennis P. Healy, Department of Pharmacology, Box 1215, Mount Sinai School of Medicine, One Gustave L. Levy Pl, New York, NY 10029. E-mail d_healy{at}smtplink.mssm.edu

Abstract—Aminopeptidase A (APA) is the principal enzyme that metabolizes angiotensin II (Ang II) to angiotensin III. Previously, we showed that kidney APA was elevated in spontaneously hypertensive rats and was reduced after angiotensin-converting enzyme inhibition. In the present study, we sought to determine whether kidney APA expression was altered after chronically elevated Ang II, either exogenously delivered via osmotic minipumps or endogenously produced in two-kidney, one clip (2K1C) hypertensive rats. Ang II (200 ng · kg-1 · min-1) was infused subcutaneously for 1 or 2 weeks by osmotic minipumps, and 2K1C rats were tested 4 weeks after unilateral renal artery clipping. Blood pressure was not significantly elevated in the Ang II–infused animals but was significantly increased at 3 and 4 weeks in the 2K1C animals. APA was significantly elevated approximately 2-fold in kidney cortical membranes from Ang II–infused animals but was decreased 45% in the clipped kidney and 18% in the nonclipped kidneys from 2K1C animals. Isolated glomeruli from Ang II–infused animals and the nonclipped kidneys from 2K1C animals had markedly higher APA activity and immunoreactivity. Likewise, histochemical and immunohistochemical studies indicated that APA levels were increased in glomeruli from angiotensin-infused animals and in both nonclipped and clipped kidneys from 2K1C animals. In contrast, tubular APA was decreased in tubular elements from 2K1C animals, most markedly in the clipped kidneys. Thus, despite the increase in glomerular APA expression in kidneys from 2K1C animals, the decrease in tubular APA expression is more extensive and accounts for the measured reduction in total APA in cortical homogenates. Because clipped kidneys are not exposed to high blood pressure, these results suggest that glomerular APA expression is positively regulated and tubular APA negatively regulated by Ang II. These results further suggest that changes in kidney APA expression could influence the progression of angiotensin-dependent hypertension.


Key Words: aminopeptidases • angiotensin II • angiotensin III • kidney glomerulus • proximal renal tubules




This article has been cited by other articles:


Home page
HypertensionHome page
S. H. Padia, B. A. Kemp, N. L. Howell, M.-C. Fournie-Zaluski, B. P. Roques, and R. M. Carey
Conversion of Renal Angiotensin II to Angiotensin III Is Critical for AT2 Receptor-Mediated Natriuresis In Rats
Hypertension, February 1, 2008; 51(2): 460 - 465.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. J. FitzGerald, B. A. Murray, and D. J. Walsh
Hypotensive Peptides from Milk Proteins
J. Nutr., April 1, 2004; 134(4): 980S - 988S.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Ino, C. Uehara, F. Kikkawa, H. Kajiyama, K. Shibata, T. Suzuki, E. E. Khin, M. Ito, M. Takeuchi, A. Itakura, et al.
Enhancement of Aminopeptidase A Expression during Angiotensin II-Induced Choriocarcinoma Cell Proliferation through AT1 Receptor Involving Protein Kinase C- and Mitogen-Activated Protein Kinase-Dependent Signaling Pathway
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3973 - 3982.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Troyanovskaya, G. Jayaraman, L. Song, and D. P. Healy
Aminopeptidase-A. I. cDNA cloning and expression and localization in rat tissues
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2000; 278(2): R413 - R424.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Q. Jiang, M. Troyanovskaya, G. Jayaraman, and D. P. Healy
Aminopeptidase-A. II. Genomic cloning and characterization of the rat promoter
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2000; 278(2): R425 - R434.
[Abstract] [Full Text] [PDF]